Annick Desjardins, Md

This phase 2 trial tests whether adding a dendritic cell vaccine and an immune-boosting drug (varlilumab) to standard chemotherapy can help people with newly diagnosed glioblastoma live longer. About 43 participants will receive the vaccine plus temozolomide, with some also getti…